Dorzolamide hydrochloride is the hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions. Distributed throughout many cells and tissues, various carbonic anhydrases play important roles in mineral and metabolic homeostasis. It is grouped under the following drug class(es): Carbonic anhydrase inhibitors and Sulfones. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Trusopt and Cosopt. Its PubChem CID is 6918132.
Dorzolamide hydrochloride
| CAS No | 130693-82-2 |
|---|---|
| Molecular Formula | C10H17ClN2O4S3 |
| Molecular Weight | 360.9 g/mol |
| Synonyms | (4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dorzolamide hydrochloride is the hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions.
The listed CAS number is 130693-82-2.
The listed molecular formula is C10H17ClN2O4S3.
The listed molecular weight is 360.9 g/mol.
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride.
The source lists Trusopt and Cosopt.